Minot Wealth Management’s AbbVie ABBV Stock Holding History

Minot Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$10.1M	Sell	65,714 -447	-0.7%	-$68.3K	2.59%	6
2022 Q1	$10.7M	Buy	66,161 +800	+1%	+$116K	2.31%	7
2021 Q4	$8.85M	Buy	65,361 +1,035	+2%	+$122K	1.7%	13
2021 Q3	$6.94M	Buy	64,326 +3,657	+6%	+$418K	1.5%	14
2021 Q2	$7.15M	Buy	60,669 +3,671	+6%	+$413K	1.56%	14
2021 Q1	$6.17M	Buy	56,998 +4,804	+9%	+$514K	1.57%	12
2020 Q4	$5.59M	Buy	52,194 +8,937	+21%	+$859K	1.67%	11
2020 Q3	$3.79M	Buy	43,257 +6,282	+17%	+$591K	1.43%	19
2020 Q2	$3.63M	Buy	36,975 +14,396	+64%	+$1.27M	1.81%	12
2020 Q1	$1.72M	Buy	22,579 +17,885	+381%	+$1.52M	1.23%	27
2019 Q4	$409K	Buy	+4,694	New	+$390K	0.19%	93

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Minot Wealth Management's ABBV Position: Q2 2022 in Review

Minot Wealth Management reduced its AbbVie (ABBV) stake by 0.68% in Q2 2022, selling an estimated $68.3K and leaving 65,714 shares worth $10.1M. The position accounts for 2.59% of the portfolio, ranked #6.

Minot Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 11 quarters since. The position peaked at $10.7M in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Minot Wealth Management held 65,714 shares of AbbVie worth $10.1M as of Q2 2022.
Minot Wealth Management sold 447 AbbVie shares in Q2 2022, an estimated $68.3K.
AbbVie made up 2.59% of Minot Wealth Management's portfolio in Q2 2022, its #6 holding.
Minot Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 11 quarters since.
Minot Wealth Management's AbbVie position peaked at $10.7M in Q1 2022.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.